US case analysis: Myriad at the Supreme Court

Managing IP Correspondent

August 31, 2013

The subject of gene patentability is one of the most controversial topics in life sciences. In June 2013, the US Supreme Court reached a unanimous decision in the Association for Molecular Pathology v Myriad Genetics. It stated that companies cannot patent parts of naturally occurring human genes. Managing IP sat down with Fitzpatrick Cella Harper & Scinto attorneys Robert Fischer, John Carlin and Joshua Rothman to discuss the ruling

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

Managing IP Correspondent

More from across our site

Patents

Teamwork, mentorship and cooperation concept. Employees giving hands and helping colleagues to walk upstairs. Vector illustration.

Pipeline programmes: how firms encourage juniors

Counsel at five US firms explain how they get less experienced attorneys ready for conducting oral arguments

Rani Mehta, December 06, 2024

Patents

This week on MIP: Tesla and Avanci in court | Burberry TM claim

Tesla and Avanci’s FRAND battle, a boost for UK artists concerning royalty payments and lawyer moves involving White & Case and Fieldfisher were among the top talking points

Max Walters, December 06, 2024

Patents

Sifting through pitches: how Finnegan evaluates AI tools

Finnegan partners outline how the firm determines whether AI tools are safe to use and if they are a worthwhile investment

Rani Mehta, December 06, 2024

Patents

Flat illustration of business leader pointing direction riding rocket guiding team success innovation startup boost partnership productivity

Realising dreams: new hire eyes start-up work at Barclay Damon

Bill Braunlin was drawn to the firm because of its work with start-ups and universities, as well as its employees’ industry experience

Rani Mehta, December 06, 2024

Patents

100 days in: How White & Case litigator approaches BD

Melissa Anyetei discusses how she’s building her practice and reveals the challenges of working at a larger firm

Rani Mehta, December 05, 2024

Trademarks

Uncertainty around trademark revocation in Türkiye: should applications be submitted?

Lawyers at Aksoy IP discuss why a delay in implementing a new procedure for cancelling trademarks in Türkiye is causing a headache for practitioners

Dogukan Aksoy, December 05, 2024

Patents

Going for gold: why PE firms seek out IP businesses

Private equity firms explain how external funding and expertise can help IP firms and reveal what they look for before investing

Sukanya Sarkar, December 05, 2024

Patents

Electronic cogarette vape on a dark background with steam

UPC latest: Infringement by equivalents | First FRAND ruling | E-cigarette wars

Our latest UPC update covers first-instance decisions, upcoming hearings, and other significant developments

James Nurton, December 05, 2024

Patents

Electric car charging at a gas station in the city, industrial landscape, neon elements, healthy environment without harmful emissions. Eco concept. generative AI

Fully charged: how Avanci got EV licensing programme ready to go

Managing IP goes behind the scenes to uncover what happens when setting up an SEP licensing programme for electric vehicle chargers, and discovers why law firms play a crucial role

Max Walters, December 04, 2024

What Corporates Want

What Corporates Want: Law firms urged to up their responsiveness game

Exclusive data and in-house analysis show that law firms are able to respond quickly when engaging with in-house clients but struggle to make the grade when it comes to the quality of their answers

Max Walters, December 04, 2024